First Time Loading...

Atreca Inc
NASDAQ:BCEL

Watchlist Manager
Atreca Inc Logo
Atreca Inc
NASDAQ:BCEL
Watchlist
Price: 0.0962 USD 7.13% Market Closed
Updated: May 3, 2024

Atreca Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Atreca Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Atreca Inc
NASDAQ:BCEL
Cash from Financing Activities
$3.9m
CAGR 3-Years
-69%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Atreca Inc's Cash from Financing Activities?
Cash from Financing Activities
3.9m USD

Based on the financial report for Dec 31, 2022, Atreca Inc's Cash from Financing Activities amounts to 3.9m USD.

What is Atreca Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-35%

Over the last year, the Cash from Financing Activities growth was -28%. The average annual Cash from Financing Activities growth rates for Atreca Inc have been -69% over the past three years , -35% over the past five years .